Literature DB >> 26273569

Establishing Composite Cognitive Endpoints for Use in Preclinical Alzheimer's Disease Trials.

J B Langbaum1, S Hendrix2, N Ayutyanont1, D A Bennett3, R C Shah3, L L Barnes3, F Lopera4, E M Reiman1, P N Tariot1.   

Abstract

Entities:  

Year:  2015        PMID： 26273569      PMCID： PMC4532285          DOI： 10.14283/jpad.2015.46

Source DB:  PubMed          Journal:  J Prev Alzheimers Dis        ISSN： 2274-5807


× No keyword cloud information.
  9 in total

1.  Overview and findings from the religious orders study.

Authors:  David A Bennett; Julie A Schneider; Zoe Arvanitakis; Robert S Wilson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

2.  Overview and findings from the rush Memory and Aging Project.

Authors:  David A Bennett; Julie A Schneider; Aron S Buchman; Lisa L Barnes; Patricia A Boyle; Robert S Wilson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

3.  The Minority Aging Research Study: ongoing efforts to obtain brain donation in African Americans without dementia.

Authors:  Lisa L Barnes; Raj C Shah; Neelum T Aggarwal; David A Bennett; Julie A Schneider
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

4.  An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.

Authors:  Jessica B Langbaum; Suzanne B Hendrix; Napatkamon Ayutyanont; Kewei Chen; Adam S Fleisher; Raj C Shah; Lisa L Barnes; David A Bennett; Pierre N Tariot; Eric M Reiman
Journal:  Alzheimers Dement       Date:  2014-04-21       Impact factor: 21.566

Review 5.  Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.

Authors:  Eric M Reiman; Jessica B S Langbaum; Adam S Fleisher; Richard J Caselli; Kewei Chen; Napatkamon Ayutyanont; Yakeel T Quiroz; Kenneth S Kosik; Francisco Lopera; Pierre N Tariot
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 6.  The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.

Authors:  Napatkamon Ayutyanont; Jessica B S Langbaum; Suzanne B Hendrix; Kewei Chen; Adam S Fleisher; Michel Friesenhahn; Michael Ward; Camilo Aguirre; Natalia Acosta-Baena; Lucìa Madrigal; Claudia Muñoz; Victoria Tirado; Sonia Moreno; Pierre N Tariot; Francisco Lopera; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2014-06       Impact factor: 4.384

7.  Neuropsychological study of familial Alzheimer's disease caused by mutation E280A in the presenilin 1 gene.

Authors:  Juan Carlos Arango Lasprilla; Jaime Iglesias; Francisco Lopera
Journal:  Am J Alzheimers Dis Other Demen       Date:  2003 May-Jun       Impact factor: 2.035

8.  The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.

Authors:  Michael C Donohue; Reisa A Sperling; David P Salmon; Dorene M Rentz; Rema Raman; Ronald G Thomas; Michael Weiner; Paul S Aisen
Journal:  JAMA Neurol       Date:  2014-08       Impact factor: 18.302

Review 9.  Measuring clinical progression in MCI and pre-MCI populations: enrichment and optimizing clinical outcomes over time.

Authors:  Suzanne B Hendrix
Journal:  Alzheimers Res Ther       Date:  2012-07-13       Impact factor: 6.982
  9 in total
  6 in total

Review 1.  Detectable Neuropsychological Differences in Early Preclinical Alzheimer's Disease: A Meta-Analysis.

Authors:  S Duke Han; Caroline P Nguyen; Nikki H Stricker; Daniel A Nation
Journal:  Neuropsychol Rev       Date:  2017-05-11       Impact factor: 7.444

2.  Computerized paired associate learning performance and imaging biomarkers in older adults without dementia.

Authors:  Corinne Pettigrew; Anja Soldan; Rostislav Brichko; Yuxin Zhu; Mei-Cheng Wang; Kwame Kutten; Murat Bilgel; Susumu Mori; Michael I Miller; Marilyn Albert
Journal:  Brain Imaging Behav       Date:  2021-10-23       Impact factor: 3.224

3.  Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment.

Authors:  Dai Wang; Tim Schultz; Gerald P Novak; Susan Baker; David A Bennett; Vaibhav A Narayan
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 4.  Religious Orders Study and Rush Memory and Aging Project.

Authors:  David A Bennett; Aron S Buchman; Patricia A Boyle; Lisa L Barnes; Robert S Wilson; Julie A Schneider
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 5.  A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease.

Authors:  Francesco Panza; Bruno P Imbimbo; Madia Lozupone; Giancarlo Logroscino
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

6.  Feasibility of a multi-modal exercise program on cognition in older adults with Type 2 diabetes - a pilot randomised controlled trial.

Authors:  M L Callisaya; R M Daly; J E Sharman; D Bruce; T M E Davis; T Greenaway; M Nolan; R Beare; M G Schultz; T Phan; L C Blizzard; V K Srikanth
Journal:  BMC Geriatr       Date:  2017-10-16       Impact factor: 3.921
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.